News - MedTech

ICO fines bankrupt 23andMe for ‘profoundly damaging breach’

The Information Commissioner’s Office (ICO) has fined genetic testing company 23andMe £2.31m. ...

How AI startups are disrupting healthcare: From diagnostics to sleep therapy

Introduction Healthcare is experiencing a seismic shift, driven by artificial intelligence (AI) sta...

MedTech developing therapies for heart failure raises extra £5m

Cardiff-based MedTech Ceryx Medical has closed a fresh £5m funding round, bringing the company’s ...

Female-founded virtual cancer clinic raises £3m funding round

A female-led virtual cancer clinic has now raised a total of £7.7m funding after closing a new £3m...

Royal College of Art spinout making IV drips safer raises £300k

Chesham-based Flomark Ltd, has secured £300,000 in funding as it looks to accelerate the developmen...

Manchester spinout raises £1.8m to treat chronic diseases

Apini, a small molecule drug development programme being advanced by Syncona’s accelerator Slingsh...

MedTech given £860k Innovate UK grant to detect colorectal cancer

A biomarker discovery and diagnostics startup has been awarded £860,000 in funding from Innovate UK...

BioTech acquires Toronto-based Awakn

Clinical-stage BioTech Solvonis has acquired Toronto-based Awakn, expanding its research and develop...

BioTech CellCentric announces new chief financial officer

Cambridge-based BioTech CellCentric has appointed Celia Economides as its new chief financial office...

BioNTech unveils plan to invest £1bn in the UK

World-leading biopharmaceutical company BioNTech has announced a planned £1bn investment into the U...

AstraZeneca agrees £750m deal for EsoBiotec

AstraZeneca has agreed a deal to acquire EsoBiotec for up to £750m. The acquisition includes the...

CellCentric raises £90m to prevent cancer deaths

Cancer-fighting MedTech CellCentric has raised £90m in fresh funding. The Series C round will su...

Subscribe to our newsletter

    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.